Serum ECP levels were assessed in all participants following diagnosis. These assessments were conducted using the Phadia ImmunoCAP system ECP FEIA (Phadia AB), in accordance with the manufacturer's instruction. The normal range of serum ECP in the laboratory-established patient population was 2.0–18.0 µg/L [15 (link)].